{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:30:33Z","timestamp":1787704233705,"version":"build-2784847793"},"reference-count":45,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Even if its completed form is complex, cancer originates from one or two events that happened to a single cell. A simplified model can play a role in understanding how cancer initiates at the beginning. The pathophysiology of leukemia has been studied in the most detailed manner among all human cancers. In this review, based on milestone papers and the latest research developments in hematology, acute promyelocytic leukemia (APL), chronic myeloid leukemia (CML), and acute myeloid leukemia (AML) with RUNX1-RUNX1T1 are selected to consider minimal requirements for cancer initiation. A one-hit model can be applied to the initiation of APL and CML whereas a two-hit model is more suitable to the initiation of AML with RUNX1-RUNX1T1 and other AMLs. Even in cancer cells with multiple genetic abnormalities, there must be a few mutant genes critical for the mutant clone to survive and proliferate. Such genes should be identified and characterized in each case in order to develop individualized target therapy.<\/jats:p>","DOI":"10.3390\/cancers16173109","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T04:15:01Z","timestamp":1725855301000},"page":"3109","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Minimal Requirements for Cancer Initiation: A Comparative Consideration of Three Prototypes of Human Leukemia"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4339-1406","authenticated-orcid":false,"given":"Toshiyuki","family":"Hori","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, Kusatsu 525-8577, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1158\/0008-5472.CAN-07-6611","article-title":"A history of cancer chemotherapy","volume":"68","author":"DeVita","year":"2008","journal-title":"Cancer Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/255197a0","article-title":"Mutation selection and the natural history of cancer","volume":"255","author":"Cairns","year":"1975","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1146\/annurev-genet-120213-092314","article-title":"Cancer: Evolution within a lifetime","volume":"48","author":"Gerlinger","year":"2014","journal-title":"Annu. Rev. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.cell.2024.02.009","article-title":"Embracing cancer complexity: Hallmarks of systemic disease","volume":"187","author":"Swanton","year":"2024","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/bjc.1969.41","article-title":"The two \u201chit\u201d and multiple \u201chit\u201d theories of carcinogenesis","volume":"23","author":"Ashley","year":"1969","journal-title":"Br. J. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: Statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/323643a0","article-title":"A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma","volume":"323","author":"Friend","year":"1986","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Kooi, I.E., Mol, B.M., Massink, M.P., Ameziane, N., Meijers-Heijboer, H., Dommering, C.J., van Mil, S.E., de Vries, Y., van der Hout, A.H., and Kaspers, G.J. (2016). Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes. Sci. Rep., 6.","DOI":"10.1038\/srep25264"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature13813","article-title":"Rb suppresses human cone-precursor-derived retinoblastoma tumours","volume":"514","author":"Xu","year":"2014","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMra1803083","article-title":"Retinoblastoma Origins and Destinations","volume":"390","author":"Cobrinik","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1182\/blood.V93.4.1197","article-title":"The nuclear topography of ABL, BCR, PML, and RARalpha genes: Evidence for gene proximity in specific phases of the cell cycle and stages of hematopoietic differentiation","volume":"93","author":"Neves","year":"1999","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"106900","DOI":"10.1016\/j.isci.2023.106900","article-title":"How chromosomal translocations arise to cause cancer: Gene proximity, trans-splicing, and DNA end joining","volume":"26","author":"Streb","year":"2023","journal-title":"iScience"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/sj.leu.2401722","article-title":"The incidence of acute promyelocytic leukemia appears constant over most of a human lifespan, implying only one rate limiting mutation","volume":"14","author":"Vickers","year":"2000","journal-title":"Leukemia"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ccell.2017.10.002","article-title":"Acute Promyelocytic Leukemia: A Paradigm for Oncoprotein-Targeted Cure","volume":"32","author":"Pandolfi","year":"2017","journal-title":"Cancer Cell."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00277-021-04472-5","article-title":"The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients","volume":"101","author":"Dunn","year":"2022","journal-title":"Ann. Hematol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.tcb.2018.06.001","article-title":"Hematopoietic Hierarchy\u2014An Updated Roadmap","volume":"28","author":"Zhang","year":"2018","journal-title":"Trends Cell Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1182\/blood-2007-10-118331","article-title":"Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells","volume":"112","author":"Taussig","year":"2008","journal-title":"Blood"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s12015-021-10308-6","article-title":"Acute Myeloid Leukemia Stem Cells: Origin, Characteristics, and Clinical Implications","volume":"18","author":"Long","year":"2022","journal-title":"Stem Cell. Rev. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev-pathmechdis-031621-025610","article-title":"Cancer as a Disease of Development Gone Awry","volume":"19","author":"Stanger","year":"2024","journal-title":"Annu. Rev. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.devcel.2021.05.018","article-title":"Niches that regulate stem cells and hematopoiesis in adult bone marrow","volume":"56","author":"Comazzetto","year":"2021","journal-title":"Dev. Cell."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1016\/j.cell.2024.04.013","article-title":"Mapping the cellular biogeography of human bone marrow niches using single-cell transcriptomics and proteomic imaging","volume":"187","author":"Bandyopadhyay","year":"2024","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/s41375-019-0490-0","article-title":"Chronic myeloid leukemia stem cells","volume":"33","author":"Houshmand","year":"2019","journal-title":"Leukemia"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"14931","DOI":"10.1073\/pnas.0607006103","article-title":"The age incidence of chronic myeloid leukemia can be explained by a one-mutation model","volume":"103","author":"Michor","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ccr.2007.11.003","article-title":"Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo","volume":"12","author":"Zhao","year":"2007","journal-title":"Cancer Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/leu.2010.287","article-title":"Janus kinase 2 regulates Bcr-Abl signaling in chronic myeloid leukemia","volume":"25","author":"Samanta","year":"2011","journal-title":"Leukemia"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1038\/sj.onc.1210979","article-title":"BCR-ABL oncogenic transformation of NIH 3T3 fibroblasts requires the IL-3 receptor","volume":"27","author":"Tao","year":"2008","journal-title":"Oncogene"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Honda, T., Morii, M., Nakayama, Y., Suzuki, K., Yamaguchi, N., and Yamaguchi, N. (2018). v-Src-driven transformation is due to chromosome abnormalities but not Src-mediated growth signaling. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-19599-1"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev-pathol-012615-044454","article-title":"Pathogenesis of Myeloproliferative Disorders","volume":"11","author":"Nangalia","year":"2016","journal-title":"Annu. Rev. Pathol."},{"key":"ref_34","first-page":"109","article-title":"Identificaton of a translocation with quinacrine fluorescence in a patient with acute leukemia","volume":"16","author":"Rowley","year":"1973","journal-title":"Ann. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"Estey","year":"2017","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1182\/bloodadvances.2019000168","article-title":"An update on the molecular pathogenesis and potential therapeutic targeting of AML with t(8;21)(q22;q22.1);RUNX1-RUNX1T1","volume":"4","author":"Aljurf","year":"2020","journal-title":"Blood Adv."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1182\/blood.V99.10.3801","article-title":"In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia","volume":"99","author":"Wiemels","year":"2002","journal-title":"Blood"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"12475","DOI":"10.1038\/ncomms12475","article-title":"Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia","volume":"7","author":"Hirsch","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1074-7613(00)00042-X","article-title":"Haploinsufficiency of AML1 affects the temporal and spatial generation of hematopoietic stem cells in the mouse embryo","volume":"13","author":"Cai","year":"2000","journal-title":"Immunity"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1535-6108(02)00016-8","article-title":"Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia","volume":"1","author":"Higuchi","year":"2002","journal-title":"Cancer Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/leu.2014.4","article-title":"High number of additional genetic lesions in acute myeloid leukemia with t(8;21)\/RUNX1-RUNX1T1: Frequency and impact on clinical outcome","volume":"28","author":"Krauth","year":"2014","journal-title":"Leukemia"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood-2015-12-688705","article-title":"Comprehensive mutational profiling of core binding factor acute myeloid leukemia","volume":"127","author":"Duployez","year":"2016","journal-title":"Blood"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic Classification and Prognosis in Acute Myeloid Leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0092-8674(02)01014-0","article-title":"The beta-catenin\/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells","volume":"111","author":"Sancho","year":"2002","journal-title":"Cell"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"AACR Project GENIE Consortium (2017). AACR Project GENIE: Powering Precision Medicine through an International Consortium. Cancer Discov., 7, 818\u2013831.","DOI":"10.1158\/2159-8290.CD-17-0151"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/17\/3109\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:51:46Z","timestamp":1760111506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/17\/3109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":45,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["cancers16173109"],"URL":"https:\/\/doi.org\/10.3390\/cancers16173109","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,9]]}}}